Drugs / Fermagate
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT00436683 | Feb 2007 → Jan 2008 | chronic renal failure syndrome | Ineos Healthcare Limited | Completed | No outcome recorded |
| Phase 2 | NCT00358722 | Jul 2006 → May 2008 | chronic renal failure syndrome | Ineos Healthcare Limited | Terminated | No outcome recorded |
| Phase 2 | NCT00317694 | Mar 2006 → Jun 2007 | chronic renal failure syndrome | Ineos Healthcare Limited | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00844662 | Jul 2009 → Sep 2011 | chronic renal failure syndrome | Ineos Healthcare Limited | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fermagate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00317694 ↗ |
| Known as | Alpharen | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297751 ↗ |
| Known as | Fermagato | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297751 ↗ |